Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Elucidating the Pathogenic Effects of Myofibroblasts in Pancreatic Cancer

FY 2021-22

Summary
Among the leading causes of solid cancer-related deaths in Canada, pancreatic cancer has the lowest five-year survival rate with most patients succumbing to pancreatic ductal adenocarcinoma (PDAC). Difficulties in the early detection of PDAC, combined with its rapid disease progression and ineffective traditional treatments, highlight the importance of developing new therapeutic strategies. Under normal circumstances, fibroblasts are cells that contribute to the formation and maintenance of tissue structures. Within the PDAC tumour microenvironment, however, there is an abundance of activated fibroblasts termed myofibroblasts that are not found in healthy tissues. These myofibroblasts shape tumour structures, dictate tumour expansions in PDAC and influence immune cell infiltration into the tumours. A prominent subset of these myofibroblasts expresses and secretes collagen triple helix repeat containing 1 (CTHRC1), a known cancer-associated protein. Yet, the roles of CTHRC1+ myofibroblasts and the secreted CTHRC1 protein on PDAC pathogenesis are unclear. I hypothesize that CTHRC1+ myofibroblasts and myofibroblast-derived CTHRC1 promote PDAC tumour development and metastasis. To address my hypothesis, I will use genetically engineered mouse models to examine the effects of depleting CTHRC1+ myofibroblasts and the CTHRC1 protein in the context of PDAC. As a key player in modulating the tumour microenvironment, elucidating the mechanisms and functions of these fibroblasts would augment our fundamental knowledge of many solid tumour cancers. Specifically, a breakthrough in understanding the role of myofibroblasts and the secreted protein CTHRC1 would introduce unique insights for effectively targeting PDAC and improve disease outcomes for many Canadians.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
480739
Name
Cheng Maye F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the Pathogenic Effects of Myofibroblasts in Pancreatic Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fibroblast; Immunology; Immunotherapy; Pancreatic Cancer; Pdac; Solid Tumors
Abstract
Among the leading causes of solid cancer-related deaths in Canada, pancreatic cancer has the lowest five-year survival rate with most patients succumbing to pancreatic ductal adenocarcinoma (PDAC). Difficulties in the early detection of PDAC, combined with its rapid disease progression and ineffective traditional treatments, highlight the importance of developing new therapeutic strategies. Under normal circumstances, fibroblasts are cells that contribute to the formation and maintenance of tissue structures. Within the PDAC tumour microenvironment, however, there is an abundance of activated fibroblasts termed myofibroblasts that are not found in healthy tissues. These myofibroblasts shape tumour structures, dictate tumour expansions in PDAC and influence immune cell infiltration into the tumours. A prominent subset of these myofibroblasts expresses and secretes collagen triple helix repeat containing 1 (CTHRC1), a known cancer-associated protein. Yet, the roles of CTHRC1+ myofibroblasts and the secreted CTHRC1 protein on PDAC pathogenesis are unclear. I hypothesize that CTHRC1+ myofibroblasts and myofibroblast-derived CTHRC1 promote PDAC tumour development and metastasis. To address my hypothesis, I will use genetically engineered mouse models to examine the effects of depleting CTHRC1+ myofibroblasts and the CTHRC1 protein in the context of PDAC. As a key player in modulating the tumour microenvironment, elucidating the mechanisms and functions of these fibroblasts would augment our fundamental knowledge of many solid tumour cancers. Specifically, a breakthrough in understanding the role of myofibroblasts and the secreted protein CTHRC1 would introduce unique insights for effectively targeting PDAC and improve disease outcomes for many Canadians.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cheng, Maye F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~